BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 6458007)

  • 1. [Management of virilization with an antiandrogen-containing contraceptive].
    Apró G; Sas M
    Orv Hetil; 1981 Jul; 122(30):1821-4. PubMed ID: 6458007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of moderately severe virilism of women with Diane and Androcur 10].
    Döring HF; Ilgner M
    Z Hautkr; 1983 May; 58(10):761-7. PubMed ID: 6224353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical treatment results of treating androgenization symptoms in women with preparation Diane-35].
    Marianowski L; Cyganek A; Grzechocińska B
    Wiad Lek; 1994 Oct; 47(19-20):745-6. PubMed ID: 7483620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of virilizing syndromes. Comparative clinical studies of 2 antiandrogen-active gestagens (cyproterone acetate, megestrol acetate].
    Grund E; Schmidt-Elmendorff H
    Med Welt; 1975 Nov; 26(48):2180-7. PubMed ID: 128684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyproterone acetate - ethinylestradiol treatment of hirsutism, acne, seborrhea and alopecia.
    Nardi M; De Aloysio D; Busacchi P; Flamigni C
    Acta Eur Fertil; 1975 Jun; 6(2):153-65. PubMed ID: 127497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
    Kaiser E
    Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):738-42. PubMed ID: 2948866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-androgens. Their use in dermatology].
    Montero ED; Arevalo A; Michelotti M
    Med Cutan Ibero Lat Am; 1981; 9(4):275-84. PubMed ID: 6456390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
    Rubina VV; Korchevaia TA; Kravchenko LIa
    Vestn Dermatol Venerol; 1986; (7):21-5. PubMed ID: 2945335
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of oral contraceptives on acne. Apropos of a comparative study of Varnoline vs Diane in 69 women with acne].
    Levrier M; Degrelle H; Bestaux Y; Bourry-Moreno M; Brun JP; Sailly F
    Rev Fr Gynecol Obstet; 1988; 83(7-9):573-6. PubMed ID: 2973646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contraception in androgenised women with a low-dose cyproterone-acetate containing one-phase preparation (author's transl)].
    Moltz L; Meckies J; Hammerstein J
    Dtsch Med Wochenschr; 1979 Sep; 104(39):1376-82. PubMed ID: 157869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open study of Triphasil and Diane 50 in the treatment of acne.
    Wishart JM
    Australas J Dermatol; 1991; 32(1):51-4. PubMed ID: 1834045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of antiandrogens in the female].
    Moltz L; Schwartz U; Hammerstein J
    Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of acne and seborrhea using antiandrogens].
    Keller PJ; Fetz A; Schär A; Floersheim Y
    Schweiz Med Wochenschr; 1978 Oct; 108(42):1640-2. PubMed ID: 151916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of medium severe androgenizing symptoms in women].
    Turina D; Keller PJ; Floersheim Y
    Gynakol Rundsch; 1980 Jun; 20 Suppl 1():81-3. PubMed ID: 6452320
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term studies with an anti-androgen/estrogen combination preparation of its effectiveness, liver tolerance and lipid metabolism in females].
    Kaiser E; Gruner S
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):298-303. PubMed ID: 1830560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol.
    Cremoncini C; Vignati E; Libroia A
    Acta Eur Fertil; 1976 Dec; 7(4):299-314. PubMed ID: 140576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive].
    Mehrl J
    Fortschr Med; 1988 Aug; 106(25):50-1. PubMed ID: 2971600
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
    Gollnick H; Albring M; Brill K
    Ann Endocrinol (Paris); 1999 Sep; 60(3):157-66. PubMed ID: 10520404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.